Macrophage activation syndrome in a patient with systemic lupus erythematosus (SLE) and dual viremia
Macrophage Activation Syndrome (MAS) is a potentially fatal inflammatory condition that can rapidly lead to multi-organ failure if inadequately treated. Also, known as secondary Hemophagocytic Lymphohistiocytosis (sHLH), MAS is commonly seen as a complication of systemic inflammatory disorders, like...
Main Authors: | Shankar Awasthi, Sunita Upreti |
---|---|
Format: | Article |
Language: | English |
Published: |
Greater Baltimore Medical Center
2020-09-01
|
Series: | Journal of Community Hospital Internal Medicine Perspectives |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/20009666.2020.1787811 |
Similar Items
-
Hemophagocytic lymphohistiocytosis: Uncommon systemic inflammatory clinical syndrome
by: Paparao N, et al.
Published: (2016-09-01) -
Hemophagocytic lymphohistiocytosis and macrophage activation syndrome: two rare sides of the same devastating coin
by: Flavio Sztajnbok, et al.
Published: (2024-04-01) -
Erythroderma and persistent erythema in adult-onset Still disease associated with macrophage activation syndrome
by: Victoria M. Madray, MD, et al.
Published: (2021-11-01) -
Hemophagocytic syndrome in systemic lupus erythematosus
by: Agata Liszewska, et al.
Published: (2019-08-01) -
Malignancy-induced hemophagocytic lymphohistiocytosis in a case of signet ring cell carcinoma of the stomach
by: Subramaniam Ramkumar
Published: (2021-01-01)